{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:00:20Z","timestamp":1649095220734},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1986,3]]},"DOI":"10.1007\/bf01262957","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T02:25:27Z","timestamp":1111631127000},"page":"47-58","source":"Crossref","is-referenced-by-count":0,"title":["Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression"],"prefix":"10.1007","volume":"66","author":[{"given":"H.","family":"Loo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Benkelfat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Vanelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Olie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Scatton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0447.1982.tb05454.x","volume":"65","author":"A Aberg-Wistedt","year":"1982","unstructured":"Aberg-Wistedt A, Ross SB, Jostell KG, Sjoquist B (1982) A double blind study of zimelidine, a serotonin uptake inhibition and desipramine, a noradrenaline uptake inhibitor in endogenous depression: II. Biochemical findings. Acta Psychiatr Scand 65: 82","journal-title":"Acta Psychiatr Scand"},{"key":"CR2","unstructured":"American Psychiatric Association. Committee on Nomenclature and Statistics (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington D.C."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1246632","volume":"191","author":"L Asberg","year":"1976","unstructured":"Asberg L, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976) Serotonin depression. A biochemical subgroup within the affective disorders. Science 191: 478?480","journal-title":"Science"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/030006057900700511","volume":"7","author":"PA Baumann","year":"1979","unstructured":"Baumann PA, Maitre L (1979) Neurobiochemical aspects of maprotiline (Ludiomil) action. J Int Med Res 7: 391?400","journal-title":"J Int Med Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpsyc.1975.01760190019001","volume":"32","author":"H Beckmann","year":"1975","unstructured":"Beckmann H, Goodwin FK (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Arch Gen Psychiatry 32: 17?21","journal-title":"Arch Gen Psychiatry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","volume":"38","author":"BJ Carroll","year":"1981","unstructured":"Carroll BJ, Feinberg M, Greden JF, Tarika J, Albaba AA, Haskett RF, James JM, Kronfol Z, Lohr N, Steiner M, De Vigne JF, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Standardization, validation and clinical utility. Arch Gen Psychiatry 38: 15?22","journal-title":"Arch Gen Psychiatry"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00427352","volume":"64","author":"A Coppen","year":"1979","unstructured":"Coppen A, Rama Rao VA, Ruthven CRS, Goodwin BL, Sandler M (1979) Urinary 4 hydroxy-3-methoxy-phenylglycol is not a predictor for clinical response to maprotiline in depressive illness. Psychopharmacology 64: 95?97","journal-title":"Psychopharmacology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(72)92064-8","volume":"ii","author":"MH Ebert","year":"1972","unstructured":"Ebert MH, Post RM, Goodwin FK (1972) Effect of physical activity on urinary MHPG excretion in depressed patients. Lancet ii: 766","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1972.01750210054011","volume":"26","author":"J Fawcett","year":"1972","unstructured":"Fawcett J, Maas JW, Dekirmenjian H (1972) Depression and MHPG excretion. Arch Gen Psychiatry 26: 246?251","journal-title":"Arch Gen Psychiatry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2007-1019532","volume":"15","author":"HJ Gaertner","year":"1982","unstructured":"Gaertner HJ, Golfinopoulos G, Breyer-Pfaff V (1982) Response to maprotiline treatment in depressive patients, relationship to urinary MHPG excretion and plasma drug level. Pharmacopsychiatry 15: 170?175","journal-title":"Pharmacopsychiatry"},{"key":"CR11","first-page":"1277","volume-title":"Psychopharmacology. A generation of progress","author":"FK Goodwin","year":"1978","unstructured":"Goodwin FK, Cowdry RW, Webster MH (1978) Predictors of drug response in the affective disorders: toward and integrated approach. In: Psychopharmacology. A generation of progress. Raven Press, New York, p 1277"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archpsyc.1978.01770360014001","volume":"35","author":"LE Hollister","year":"1978","unstructured":"Hollister LE, Davis KL, Berger PA (1978) Subtypes of depression based on excretion of MHPG and response to nortriptyline. Arch Gen Psychiatry 35: 1410?1415","journal-title":"Arch Gen Psychiatry"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0024-3205(80)90373-2","volume":"27","author":"JW Huff","year":"1980","unstructured":"Huff JW, Reigle TG (1980) Effects of morphine and other centrally acting drugs on 3,4 dihydroxyphenylethyleneglycol (DOPEG-SO4) in rat brain. Life Sci 27: 1483?1488","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-462920-2.50010-6","volume-title":"MHPG: Basic mechanisms and psychopathology","author":"JI Javaid","year":"1983","unstructured":"Javaid JI, Rubinstein J, Davis JM (1983) Effect of pharmacological agents on MHPG. MHPG: Basic mechanisms and psychopathology. Academic Press, New York London, p 45"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/0024-3205(78)90563-5","volume":"23","author":"G Fur Le","year":"1978","unstructured":"Le Fur G, Kabouch H, Uzan A (1978) On the regional and specific serotonin uptake inhibition by LM 5008. Life Sci 23: 1959?1966","journal-title":"Life Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archpsyc.1982.04290090027006","volume":"39","author":"M Linnoila","year":"1982","unstructured":"Linnoila M, Karoum F, Calil HM, Kopin IJ, Potter WZ (1982) Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. Arch Gen Psychiatry 39: 1025?1028","journal-title":"Arch Gen Psychiatry"},{"key":"CR17","first-page":"1025","volume":"140","author":"M Linnoila","year":"1983","unstructured":"Linnoila M, Karoum F, Miller T, Potter WZ (1983) Reliability of urinary monoamine and metabolite output measurements in depressed patients. Am Gen Psychiatry 140: 1025?1057","journal-title":"Am Gen Psychiatry"},{"key":"CR18","doi-asserted-by":"crossref","unstructured":"Loo, H, Benkelfat C, Poirier MF, Vanelle JM, Oli\u00e9 JP, Dennis T, Scatton B (1986) Plasma 3,4-Dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression. Neuropsychobiology, in press","DOI":"10.1159\/000118243"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archpsyc.1975.01760290025002","volume":"32","author":"JW Maas","year":"1975","unstructured":"Maas JW (1975) Biogenic amines and depression: biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry 32: 1357?1361","journal-title":"Arch Gen Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archpsyc.1972.01750210060012","volume":"26","author":"JW Maas","year":"1972","unstructured":"Maas JW, Fawcett J, Dekirmenjian H (1972) Catecholamine metabolism, depressive illness and drug response. Arch Gen Psychiatry 26: 252?262","journal-title":"Arch Gen Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0033291700043269","volume":"12","author":"JW Maas","year":"1982","unstructured":"Maas JW, Kocsis JH, Bowden CL, Davis JM, Redmond DE, Hanin I, Robins E (1982) Pretreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med 12: 37?43","journal-title":"Psychol Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1176\/ajp.141.10.1159","volume":"141","author":"JW Maas","year":"1984","unstructured":"Maas JW, Koslow SH, Katz MM, Bowden CL, Davis JM, Redmond DE, Hanin I, Robins E (1984) Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatry 141: 1159?1171","journal-title":"Am J Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00427824","volume":"79","author":"D Muck Seler","year":"1983","unstructured":"Muck Seler D, Deanovic Z, Jannicky B, Jakupcevic M, Mihovilovic M (1983) Maprolitine in treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets. Psychopharmacol 79: 262?265","journal-title":"Psychopharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.1984.01790150027005","volume":"41","author":"G Muscettola","year":"1984","unstructured":"Muscettola G, Potter WZ, Pickar D, Goodwin FK (1984) Urinary 3-methoxy-4-hydroxyphenylethyleneglycol and major affective disorders. A replication and new findings. Arch Gen Psychiatry 41: 337?342","journal-title":"Arch Gen Psychiatry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1176\/ajp.134.8.914","volume":"134","author":"G Muscettola","year":"1977","unstructured":"Muscettola G, Wehr T, Goodwin FK (1977) Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. Am J Psychiatry 134: 914?916","journal-title":"Am J Psychiatry"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/B978-0-12-462920-2.50014-3","volume-title":"MHPG: basic mechanism and psychopathology","author":"WZ Potter","year":"1983","unstructured":"Potter WZ, Muscettola G, Goodwin FK (1983) Sources of variances in clinical studies of MHPG. MHPG: basic mechanism and psychopathology. Academic Press, New York London, p 145"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1176\/ajp.137.9.1090","volume":"137","author":"AH Rosenbaum","year":"1980","unstructured":"Rosenbaum AH, Schatzberg AF, Maruta T, Orsulak PJ, Cole JO, Grab EL, Schildkraut JJ (1980) MHPG as a predictor of antidepressant response to imipramine and maprotiline. Am J Psychiatry 137: 1090?1092","journal-title":"Am J Psychiatry"},{"key":"CR28","first-page":"157","volume":"11","author":"E Sachetti","year":"1976","unstructured":"Sachetti E, Smeraldi E, Cagnasso M, Biondi P, Bellodi L (1976) MHPG, amitriptyline and affective disorders: a longitudinal study. Int J Pharm Psychiatry 11: 157?162","journal-title":"Int J Pharm Psychiatry"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00652244","volume":"88","author":"B Scatton","year":"1986","unstructured":"Scatton B, Loo H, Dennis T, Benkelfat C, Gay C, Poirier-Littre MF (1986) Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression. Psychopharmacology 88: 220?225","journal-title":"Psychopharmacology"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00433498","volume":"75","author":"AF Schatzberg","year":"1981","unstructured":"Schatzberg AF, Rosenbaum AM, Orsulak PJ, Rohde NA, Maruka T, Kruger ER, Cole JO, Schildkraut JJ (1981) Toward a biochemical classification of depressive disorders. III Pretreatment urinary MHPG levels as predictor of response to treatment with maprotiline. Psychopharmacology 75: 34?38","journal-title":"Psychopharmacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509?522","journal-title":"Am J Psychiatry"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.130.6.695","volume":"130","author":"JJ Schildkraut","year":"1973","unstructured":"Schildkraut JJ (1973) Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and reducting responses to treatment: preliminary findings. Am J Psychiatry 130: 695?698","journal-title":"Am J Psychiatry"},{"key":"CR33","first-page":"1223","volume-title":"Psychopharmacology. A generation of progress","author":"JJ Schildkraut","year":"1978","unstructured":"Schildkraut JJ (1978) Current status of the catecholamine hypothesis of affective disorders. Psychopharmacology. A generation of progress. Lipton MA, Di Mascio A, Killam KF (eds) Raven Press, New York, p 1223"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0021-9673(00)82092-0","volume":"218","author":"L Semerdjian-Rouquier","year":"1981","unstructured":"Semerdjian-Rouquier L, Bossi L, Scatton B (1981) Concurrent determination of 5-HTP, 5-HT, 5-HIAA in rat and human brain and biological fluids by reversed-phase HPLC with electrochemical detection. J Chromat 218: 663?670","journal-title":"J Chromat"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/ajp.137.10.1183","volume":"137","author":"DG Spiker","year":"1980","unstructured":"Spiker DG, Edwards D, Hanin I, Neil JF, Kupfer DJ (1980) Urinary MHPG and clinical response to amitriptyline in depressed patients. Am J Psychiatry 137: 1183?1187","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01262957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01262957\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01262957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T12:49:49Z","timestamp":1586177389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01262957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,3]]}},"alternative-id":["BF01262957"],"URL":"https:\/\/doi.org\/10.1007\/bf01262957","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,3]]}}}